Han, A L
Veeneman, B A
El-Sawy, L
Day, K C
Day, M L
Tomlins, S A
Keller, E T
Article History
Received: 8 December 2016
Revised: 27 March 2017
Accepted: 14 April 2017
First Online: 15 May 2017
Competing interests
: SAT has consulted for, and received honoraria from AbbVie, Astellas, Jannsen and Ventana Medical Systems. SAT has received research support from Astellas and had a sponsored research agreement with, and has received travel support from ThermoFisher Scientific/Life Technologies. SAT is a co-founder and equity holder in Strata Oncology. MLD has consulted for and received honoraria from Pharco pharmaceutical and EEPI pharmaceutical. MLD has received research support from EEPI, Genmab and Synthon. The remaining authors declare no conflict of interest.